Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ruchi Yadav, Rachel W. Linnemann, Joanne Michelle Kahlenberg, S. Louis Bridges$suffix/text()$suffix/text(), Arlene A. Stecenko & Balázs Rada. (2020) IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction. Autoimmunity 53:8, pages 476-484.
Read now
Read now
Stephan Radoslavov Lolov, George Edrev Edrev, Stanimir Dobrev Kyurkchiev, Ivan Raichev Kehayov. (1998) Elevated Autoantibodies in Sera from Otosclerotic Patients are Related to the Disease Duration. Acta Oto-Laryngologica 118:3, pages 375-380.
Read now
Read now
Terence J. Wilkin, Linda Voss, Angela Tuck, Helen Bullen & Peter Betts. (1993) Autoantibodies to Endogenous Growth Hormone in Short Children (The Wessex Growth Study). Autoimmunity 14:1, pages 67-72.
Read now
Read now
Aron Thall, Jacqueline Etienne-decerf, Roger J. Winand & Uri Galili. (1991) The α-Galactosyl Epitope on Human Normal and Autoimmune Thyroid Cells. Autoimmunity 10:2, pages 81-87.
Read now
Read now
J-L. Diaz, D. Daneman, J. M. Martin, E. Sochett & T. J. Wilkin. (1991) The Relationship Between Insulin Autoantibodies and Islet Cell Histology in the Diabetes Prone BB Rat. Autoimmunity 11:1, pages 45-51.
Read now
Read now
T. J. Wilkin. (1990) The Primary Lesion Theory of Autoimmunity: A Speculative Hypothesis. Autoimmunity 7:4, pages 225-235.
Read now
Read now
Articles from other publishers (23)
Bert A. ’t Hart, Antonio Luchicchi, Geert J. Schenk, Peter K. Stys & Jeroen J. G. Geurts. (2021) Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis. Annals of Clinical and Translational Neurology 8:8, pages 1709-1719.
Crossref
Crossref
Bert A. 't Hart, Jordon Dunham, S. Anwar Jagessar & Yolanda S. Kap. (2016) The common marmoset (<i>Callithrix jacchus</i>): a relevant preclinical model of human (auto)immune-mediated inflammatory disease of the brain. Primate Biology 3:1, pages 9-22.
Crossref
Crossref
Marjan Vanheusden, Piet Stinissen, Bert A. ’t Hart & Niels Hellings. (2015) Cytomegalovirus: a culprit or protector in multiple sclerosis?. Trends in Molecular Medicine 21:1, pages 16-23.
Crossref
Crossref
Terence J. Wilkin. (2013) Is Autoimmunity or Insulin Resistance the Primary Driver of Type 1 Diabetes?. Current Diabetes Reports 13:5, pages 651-656.
Crossref
Crossref
T J Wilkin. (2009) The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. International Journal of Obesity 33:7, pages 716-726.
Crossref
Crossref
Bert A. ‘t Hart, Rogier Q. Hintzen & Jon D. Laman. (2009) Multiple sclerosis – a response-to-damage model. Trends in Molecular Medicine 15:6, pages 235-244.
Crossref
Crossref
Bert A. 't Hart & Luca Massacesi. (2009)
Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (
Callithrix jacchus
)
. Journal of Neuropathology & Experimental Neurology 68:4, pages 341-355.
Crossref
Crossref
Terence Wilkin. 2008. Epidemiology of Pediatric and Adolescent Diabetes. Epidemiology of Pediatric and Adolescent Diabetes
85
102
.
Michel Vierboom & Bert A. ‘t Hart. 2008. Primate Models of Children's Health and Developmental Disabilities. Primate Models of Children's Health and Developmental Disabilities
71
107
.
Bert A. 't Hart & Yvette van Kooyk. (2004) Yin–Yang regulation of autoimmunity by DCs. Trends in Immunology 25:7, pages 353-359.
Crossref
Crossref
M. KibirigeB. MetcalfR. RenukaT. J. Wilkin. (2003) Testing the Accelerator Hypothesis. Diabetes Care 26:10, pages 2865-2870.
Crossref
Crossref
D.J. Menger & R.A. Tange. (2003) The aetiology of otosclerosis: a review of the literature. Clinical Otolaryngology and Allied Sciences 28:2, pages 112-120.
Crossref
Crossref
T. Wilkin. (2014) The Author's Reply. Diabetologia 45:2, pages 289-289.
Crossref
Crossref
Bert A ’t Hart, Herbert P.M Brok, Sandra Amor & Ronald E Bontrop. (2001) The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels. Human Immunology 62:12, pages 1371-1381.
Crossref
Crossref
Kathleen N. Potter & Terence J. Wilkin. (2000) The molecular specificity of insulin autoantibodies. Diabetes/Metabolism Research and Reviews 16:5, pages 338-353.
Crossref
Crossref
Anna Macura-Biegun, Anna Pituch-Noworolska, Maria Rewicka, Bożena Mrozewicz & Jan Noworolski. (1998) Antistriational antibodies during Toxocara canis, Trichinella spiralis infections. Comparative Immunology, Microbiology and Infectious Diseases 21:2, pages 101-106.
Crossref
Crossref
Sudershan K. Bhatia & Noel R. Rose. 1996. Immunobiology. Immunobiology
239
263
.
L. L. Sidorik. (1992) Protein biosynthesis and autoimmunity. Biopolymers and Cell 8:4, pages 3-19.
Crossref
Crossref
T. J. Wilkin. (1992) Autoimmune diabetes and the germ theory of disease. Diabetologia 35:2, pages 187-189.
Crossref
Crossref
Terence J. Wilkin. (2009) Autoantibodies as mechanisms, markers, and mediators of B‐cell disease. Diabetes/Metabolism Reviews 7:2, pages 105-120.
Crossref
Crossref
Franklin H. Epstein & T.J. Wilkin. (1990) Receptor Autoimmunity in Endocrine Disorders. New England Journal of Medicine 323:19, pages 1318-1324.
Crossref
Crossref
Terence J Wilkin. (2018) Antibody Markers in Predicting Type 1 Diabetes: A Review. Journal of the Royal Society of Medicine 83:10, pages 632-636.
Crossref
Crossref
Terence J. Wilkin. (1990) Antibody markers for type 1 diabetes the issues. Trends in Endocrinology & Metabolism 1:4, pages 204-211.
Crossref
Crossref